NExT Exam 2024 Preparation is now Easier with Medicoz Community According to the pattern currently available for the NEXT examination, it will be comprised of two parts NEXT-1 and 2. NEXT-1 wil be a theoretical objective MCQ based exam which will act both as a qualifying and competitive exam whereas NEXT-2 will be a practical […]
NEET PG / NEXT, Recent Updates
Crack The NExT 2024 with Medicoz Community While, its been a while We have gone through the rigours of cracking AIPGMEE/AIIMS et al and there have been vast changes in the exam structure but the basic principles of preparation should still remain the same either it be NEET PG/ INI-CET or NEXT. 1) Sound concepts. […]
NEET PG / NEXT, Recent Updates
What is NExT Exam? While NEET PG presented its own set of difficulties for medical students, the topic of discussion today is: What’s NEXT? National Exit Test (NEXT) is a replacement for NEET PG in 2019 by the Indian government. Now the NEXT will take place from 2024 ( Expected) ,The official announcement has been […]
NEET PG / NEXT, Recent Updates
Crack Neet PG 2023 with Medicoz Community. Last Minute Tips to Crack NEET PG 2023 To GIVE YOUR 100%. • National Eligibility Cum Entrance Examination-Post Graduate (NEET PG) is a medical entrance exam that goes around in the mind of every MBBS students all the time, and getting a good rank to secure an MD/MS […]
NEET PG / NEXT, Recent Updates
Indian Hypertension control Initiative – Medicoz Community The Indian Hypertension Control Initiative (IHCI) is a joint initiative started by the MoHFW, the ICMR ,State Governments, and WHO- India to improve hypertension control to prevent deaths due to non-communicable diseases. The United Nations General Assembly has recently recognized IHCI for its effective intervention to control hypertension […]
Community Medicine Update
The Indian Public Health Standards (IPHS) guidelines come under the NHM, MoFHW and serve as an important tool to improve the quality and outcomes of the healthcare system in India.The 2022 guidelines have been developed keeping in view the following: • Recent developments in the public health system (NQAS, LaQshya, SUMAN etc.) • Impact of […]
Community Medicine Update
Brentuximab vedotin improves survival of pediatric patients with classical Hodgkin’s lymphoma Hodgkin’s lymphoma is the most common malignancy in the age group of 15-19 years and accounts for 7% of all pediatric malignancies. Brentuximab vedotin has been recently approved by FDA to treat high-risk classical Hodgkin’s lymphoma (cHL) in pediatric patients. The addition of brentuximab […]
Paediatrics Update